Examination of the Effect of Ezetimibe on Glucose Metabolism - Randomized, Double-blind, Placebo-controlled Study in Type 2 Diabetes Mellitus Patients With Hypercholesterolemia - Phase4, Protocol No. 367 (Also Known as SCH 58235, P06541)
Phase of Trial: Phase IV
Latest Information Update: 10 May 2017
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Merck & Co; Merck Sharp & Dohme
- 07 Jun 2017 Biomarkers information updated
- 12 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.